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Background: A major problem with rehabilitation interventions for neck pain is that the condition may have
multiple causes, thus a single treatment approach is seldom efficient. The present study protocol outlines a single
blinded randomised controlled trial evaluating the effect of tailored treatment for neck-shoulder pain. The
treatment is based on a decision model guided by standardized clinical assessment and functional tests with
cut-off values. Our main hypothesis is that the tailored treatment has better short, intermediate and long-term
effects than either non-tailored treatment or treatment-as-usual (TAU) on pain and function. We sub-sequentially
hypothesize that tailored and non-tailored treatment both have better effect than TAU.
Methods/Design: 120 working women with minimum six weeks of nonspecific neck-shoulder pain aged 20–65,
are allocated by minimisation with the factors age, duration of pain, pain intensity and disability in to the groups
tailored treatment (T), non-tailored treatment (NT) or treatment-as-usual (TAU). Treatment is given to the groups T
and NT for 11 weeks (27 sessions evenly distributed). An extensive presentation of the tests and treatment decision
model is provided. The main treatment components are manual therapy, cranio-cervical flexion exercise and
strength training, EMG-biofeedback training, treatment for cervicogenic headache, neck motor control training. A
decision algorithm based on the baseline assessment determines the treatment components given to each
participant of T- and NT-groups. Primary outcome measures are physical functioning (Neck Disability Index) and
average pain intensity last week (Numeric Rating Scale). Secondary outcomes are general improvement (Patient
Global Impression of Change scale), symptoms (Profile Fitness Mapping neck questionnaire), capacity to work in the
last 6 weeks (quality and quantity) and pressure pain threshold of m. trapezius. Primary and secondary outcomes
will be reported for each group with effect size and its precision.
Discussion: We have chosen not to include women with psychological ill-health and focus on biomedical aspects
of neck pain. Future studies should aim at including psychosocial aspects in a widened treatment decision model.
No important adverse events or side-effects are expected.
Trial registration: Current Controlled Trials registration ISRCTN49348025.
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Neck pain, often combined with shoulder pain, is preva-
lent in working life but in most cases a specific cause for
the pain is missing [1]. Hence, causal treatment will nor-
mally not be possible. Instead, general efforts to reduce
symptoms are often used. Current best evidence of prac-
tice for chronic nonspecific neck-shoulder pain advo-
cates a multimodal rehabilitation approach, which
usually include psychological therapy, physical training,
manual therapy and physiotherapeutic treatment [2-4].
However, knowledge on how to design the rehabilitation
to achieve best effect is mostly missing, a viewpoint
brought up by the Swedish Council on Health Technol-
ogy Assessment [5]. A reasonable assumption is that the
individual needs vary substantially due to different
underlying pain mechanisms [1], and that the rehabilita-
tion results for each patient will depend on the effects of
the treatments of these mechanisms. This is certainly
acknowledged in clinical practice today and common
practice is to evaluate the individual patient and adjust
the rehabilitation efforts to meet the need of each pa-
tient. However, no evidence based approach for such
procedures have been reported.
Further, the evidence is rather modest for effects of
specific single treatment approaches (for instance
strength training, massage, manual therapy), or combi-
nations of single treatments, despite a large increase in
interventions studies addressing neck-shoulder pain in
the last ten years [3]. This is probably due to wide group
classification like nonspecific pain rather than identifica-
tion of specific sub-populations or individual needs [6,7],
which renders it less likely to achieve significant effects
in single treatment intervention studies. At the same
time, individual rehabilitation programs derived from as-
sessment of each patient’s characteristics and needs, i.e.,
tailored rehabilitation [8], have not yet progressed nor
been tested in controlled trials. To date, we are not
aware of any study that evaluates tailored compared to
non-tailored neck treatment programs consisting of the
same treatment components. There are, however, studies
comparing different treatments where the treatment of
the individual patient is adapted to his or her condition
(see e.g. [9,10]), although it is unclear how the treat-
ments were individualized. Such pragmatic approaches
are nearly impossible to repeat and thus of limited value
for evidence based approaches.
In contrast to neck pain, tailoring or targeting treat-
ment to subgroups that share specific characteristics has
been applied for patients with nonspecific low back pain
(LBP) [11,12]. For example, Brennan et al. [11] showed
that targeted treatment based on sub-grouping accord-
ing to standardized tests, clinical signs and symptoms
leads to better outcomes in terms of improved disability,
lower cost, and higher return-to-work rates compared tonon-targeted treatment. However, a recent review indi-
cates that results of the few existing studies comparing
targeted to non-targeted treatment for LBP show only
very cautious evidence of an advantage for targeted
treatment [13].
Despite the above reasoning that single treatment modal-
ities often show weak evidence in intervention studies for
neck pain, there are several treatment methods that have
shown positive effects on pain or functioning. These in-
clude strength training for neck-shoulder muscles [2,3,14],
manual therapy [3,15], training of deep cervical flexor mus-
cles [16-18] and eye-neck-hand coordination/propriocep-
tive training [17,19]. It seems feasible that several of these
treatment components would be more effective when the
decisions regarding their application are based on careful
tailoring based on assessment of the specific dysfunctions.
Therefore, such treatments should be considered as
options in a clinical decision model provided that the
model is based on valid assessments and theoretical ration-
ale for application.
This study aims to contribute to the development of
an evidence based clinical decision model for tailored re-
habilitation of women with nonspecific neck-shoulder
pain by testing the effects of tailored versus non-tailored
treatment in a randomized controlled clinical trial
(RCT). Our study focuses on women since they are
known to be at a significantly greater risk for neck disor-
ders than men [20]. An important feature of our deci-
sion model is that it is based on an extensive assessment
of function, clinical signs and symptoms, with an at-
tempt to apply clear cut-off values based on reference
data combined with theoretical considerations. The as-
sessment will be indicative to if a specific treatment
should be applied or not. Our main hypothesis is that
this decision model based tailored rehabilitation has bet-
ter short, intermediate and long-term effects on primary
and secondary outcomes than either non-tailored re-
habilitation (same treatment components but applied
quasi-randomly) or so called treatment-as-usual (TAU).
We also hypothesize that tailored and non-tailored re-
habilitation has a better effect than TAU (for details, cf.
Current Controlled Trials registration ISRCTN49348025).
Aims
The main aim of the study is to test the hypotheses
described above by comparing the effects of tailored
treatment, non-tailored treatment and treatment-as-
usual for women with nonspecific neck-shoulder pain on
physical function, pain intensity, overall improvement
and satisfaction with treatment, work capacity, and other
objective measures of functioning. A secondary aim is to
evaluate the importance of physical and psychosocial
factors in the workplace on long-term treatment out-
comes. A third aim is to evaluate the cost-effectiveness
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The study is a prospective interventional single-centre,
single-assessor, blinded randomized controlled clinical
trial. Participants with neck-shoulder pain will be allo-
cated in a 1:1:1 ratio to either tailored (T) or non-tai-
lored (NT) treatment two to three times a week for
11 weeks (in total 27 sessions) or to treatment-as-usual
(TAU). Minimisation [21,22] is used for the allocation
sequence to minimise imbalance on the factors age, dur-
ation of pain, average pain intensity last week (Numeric
Rating Scale – NRS) and disability due to neck pain
(Neck Disability Index – NDI). Further, comparisons of
baseline assessments will be performed with a control
group without neck pain. The study will be executed in
Umeå, Sweden. Assessment (questionnaires, laboratory
and clinical assessments) of the participants with neck-
shoulder pain is made one week before and after the
treatment period, with follow-up measurements 6 and
12 month after end of treatment. The 12 month follow-
up is only performed with questionnaires. See Figure 1
for a flow chart of the study. The study was approved by
the Regional Ethical Review Board in Uppsala, Sweden
(registration number 2011/081) and informed and writ-
ten consent from participants is obtained according to
the Declaration of Helsinki.
Participants
The study sample will comprise of approximately 120
females, age 20–65, with a history of minimum six weeks
of nonspecific neck-shoulder pain and 40 healthy controls
matched on group level with respect to gender and age.
Inclusion criteria
The inclusion criteria for the participants with pain
(Table 1) are nonspecific neck-shoulder pain, defined as
pain in the neck and surrounding tissues (indicated as
dominant pain area in a pain drawing [23]) which in-
clude pain in the neck-shoulder muscles, excluding com-
plaints related to the gleno-humeral joints. In addition
to neck-shoulder pain, participants should have more
than “no disability” but less than “complete disability”
according to the Neck Disability Index (NDI) [24], and
report impaired capacity on the quality or quantity to
work the preceding month [25]. All participants with
neck pain, as well as controls, should be Swedish speak-
ing and understand written instructions in Swedish.
Exclusion criteria
Exclusion criteria for the participants with neck pain are
complaints related to trauma (questionnaire), cervicalrhizopathy, vestibular dysfunction or other specific diagno-
sis such as psychiatric, inflammatory, endocrinal, rheum-
atic, cancer, neurological, or connective tissue disorders,
stroke, heart infarct or type 1-diabetes (diagnosis from
medical doctor). Specific clinical examination protocols
[26,27] is used for confirmation at suspicion of rhizopathy
(radiating symptoms below the shoulder, indicated on pain
drawing), or vestibular dysfunction (rather strong/often diz-
ziness or balance disturbances: ≥4 on both questions, scale
1–6 [28]). Participants are also excluded if they have con-
current LBP, which is a known predictor of poor treatment
outcome in patients with neck pain [29,30] and may impair
balance [31] and cervical motor function [32]. To be
defined as having LBP, we use a case definition algorithm
[33] which is based on the distribution in a cohort of 2,329
participants with a 5-year follow-up (for references, see
[34,35]).
Further exclusion criteria are the following prognostic
factors for poor treatment outcome; low treatment expect-
ation [29,36], catastrophizing most or all of the time [29],
anxiety or depression [37]. Low treatment expectation is
assessed by the question Do you think any kind of treat-
ment or training will cure you? with five response alterna-
tives anchored by 1., “No, definitely not”, and 5., “Yes,
make me completely cured”. Participants that answer
according to response alternative 1 or 2 will be excluded.
Catastrophizing is measured with a single question taken
from the Pain Catastrophizing Scale [38]: Have you felt
your neck pain is terrible and that it’s never going to get
any better? Response alternatives are a 5-point ordinal
scale (“all; most; some; little; none; -of the time”). The
answers “most” or “all the time” indicates poor treatment
outcome [29] and will lead to exclusion. Anxiety or depres-
sion is assessed by the Hospital Anxiety and Depression
Scale with cut-off values of 10 for anxiety and 8 for depres-
sion [39]. Fibromyalgia/generalized pain is also an exclu-
sion criterion and is assessed based on the diagnostic
criteria of the American College of Rheumatology [40].
Participants with temporomandibular disorders are
excluded. The criteria for exclusion are the answer “yes”
on at least 2 out of 3 questions, combined with rating of
the problem of ≥5 on a 11-grade scale (0 =”no pro-
blems”; 10 =”maximum problems”). The three questions
are: Do you have pain in the temple, face, jaw or jaw-
joint once a week or more often? Does it hurt once a week
or more often when you open your mouth or chew? Do
you have locking in the jaw once a week or more often?
These criteria are based on Storm & Wänman [41].
Exclusion criteria are also if the participant has had
surgery in the neck, back or shoulder, or fracture in
the back or shoulder, the last 3 years. Also, fracture
in the neck or thoracic spine, luxation of a shoulder
joint the last year or severely restricted range of mo-
tion (ROM) in cervical rotation (< 30° in any
Enrollment for applicants to the study 
No further contact
Follow-Up 1. One week after intervention 
Lost to follow-up (n=  ); Discontinued intervention (n=  ) 
Allocated to tailored rehabilitation 
(target n=40) 
Follow-Up 1
Lost to follow-up (n=  ) 
Allocated to treatment-as-usual 
(target n=40). 
Baseline measurements 
Test for eligibility No
Yes
Minimisation (target n=120) 
Allocated to non-tailored rehabilitation 
(target n=40) 
Follow-Up 2. Six month after follow-up 1. 
Lost to follow-up (n=  ) 
Follow-Up 3. Twelve month after follow-up 1. 
Lost to follow-up (n=  ) 
Analysed (n=  ); Excluded from analysis (n=  )
Measurement of physical and psychosocial exposure in the work place (n= )
Figure 1 Flow-chart of research design.
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criteria.
Participants belonging to the control group should not
have ongoing problems or have had problems the latest
3 month in the neck or back and be generally healthy.
Thus, the above mentioned exclusion criteria also apply
to the control group. A summary of the inclusion and
exclusion criteria for participants with neck pain is
shown in Table 1.Recruitment procedures
Consecutive recruitment will be accomplished through
the Occupational health service of Västerbotten County
Council, Umeå municipality and Umeå University. Study
invitations is announced on the web pages of these orga-
nizations and in local newspapers, or administered
manually via staff members in the above organisations.Intervention leaders
There are four intervention leaders (ILs) who all are
experienced physiotherapists (> 3 years) in the field of
musculoskeletal disorders and with special education in
manual therapy. Before the start of the study, 12 hours
training for the therapists was accomplished involving
principles of the study, attitudes towards the partici-
pants, the role of motor learning theory in the study and
training in the treatment programs. All ILs will treat
participants of both T- and NT-groups. Follow-up meet-
ings between ILs and the project group will be held
every second month throughout the intervention period.
Treatment intervention
The intervention consists of treatment components and a
decision model based on a number of tests for tailoring the
treatment components to the individual participant. In the
design of this model we first identified specific functional
Table 1 Inclusion and exclusion criteria for participants with neck-shoulder pain
INCLUSION
Criteria Reason Assessment
Neck-shoulder region as the dominant pain area Neck pain is the focus area. Pain drawing, clinical
examination
Age 20-65 The study aim at the working population. Questionnaire
≥ 10 and≤ 68 NDI score Focus on participants with mild, moderate or
severe disability.
Questionnaire
Impaired capacity to work due to neck problems Focus on participants with disability that is




Trauma-related neck pain Focus on nonspecific neck-shoulder pain. Questionnaire
Cervical rhizopathy or vestibular dysfunction Focus on nonspecific neck-shoulder pain without
specific diagnosis that needs specific treatment.
Questionnaire, clinical
examination at suspicion
Psychiatric, inflammatory, endocrinal, rheumatic, cancer, neurological or
connective tissue disorders, stroke, heart infarct or type 1-diabetes
Focus on nonspecific neck-shoulder pain without
specific diagnosis that needs specific treatment.
Questions if diagnoses
exist from medical doctor
Concurrent low back pain Predict poor treatment outcome and affect
functioning.
Questionnaire
Fibromyalgia/generalized pain Focus on nonspecific neck pain. Questionnaire, clinical
examination at suspicion
Low treatment expectation or catastrophizing most or all of the time Prognostic factor for poor treatment outcome. Questionnaire
Anxiety or depression Prognostic factor for poor treatment outcome. Questionnaire
Temporomandibular disorders Focus on nonspecific neck-shoulder pain without
specific diagnosis that needs specific treatment.
Questionnaire
Surgery or a fracture in the neck, back or shoulder, luxation of a
shoulder joint
Risk that this affects the measurements in a
specific way, unrelated to nonspecific neck pain.
Questionnaire
Severely restricted ROM in cervical rotation or shoulder flexion Will not be able to accomplish the tests of
functioning
Clinical examination
NDI: Neck Disability Index; ROM: range of motion.
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nonspecific neck pain through an extensive review of the
literature. This resulted in five main categories of specific
functional limitations or symptom based conditions:
1. Reduced cervical mobility




5. Impaired eye-head-neck motor control
Visual impairment is also taken into consideration in
the decision model since there is support for the notion
that augmented activity levels in eye-muscles may cause
a parallel increase in muscle activity in the neck-scapular
area and cause fatigue, discomfort and pain [42].
As a second step we selected suitable tests to allow for
characterizing the individual with respect to the categories.
In the third step we selected treatments addressing these
categories.
Decision model for treatment
The decision model contains tests that should capture the
specific functional limitations or conditions addressed in
the intervention. The test results are then used for selec-
tion of treatment components for the intervention groups.
The treatment components should be logically linked to
the tests used. Our rationale when selecting tests, cut-off
levels and treatment components have been the following: Test are chosen which have the ability to detect
impaired functions of importance in nonspecific
neck-shoulder pain and that have good, or at least
acceptable, re-test reliability.
 We use tests and clinical assessments for diagnostics
of certain defined neck conditions which have empiric
and/or theoretic support for specific treatment
(trapizius myalgia and cervicogenic headache).
 Cut-offs used for the tests are based on empirical
data from the literature or from our own reference
data. In a few cases, we have adjusted the cut-off
values according to theoretical and clinical
considerations. With reference values at hand, the
cut-off could be set either to give precedence to a
high sensitivity or high specificity. We have chosen
to prioritize a high specificity in the tests in an
attempt to capture the impaired function in
question and to avoid false positive outcomes.
Further, we have chosen rigorous cut-offs at
minimum~ 20% below reference control values (see
Table 2). This is based on the assumption that 20%
difference is considered a clinical important
difference (see e.g. Dworkin et al. [43]). We have
also taken into account the relative number of
positive tests predicted by our own reference data
from a parallel study (ISRCTN trial registration
number, ISRCTN92199001), avoiding to exceed >%
of positive tests in order to keep the decision model
diversified.
Table 2 Decision model for selecting tailored treatment
Main factor Test Cut-off criteria Rationale for cut-off
1. Cervical
flexibility
1.1 Range of motion, upper
cervical
Three sub-factors a) Flexion-extension a)< 68° a) 20% below reference values of normative
control data [44] resulting in 97% specificity.
b) Passive rotation in maximal
flexed position
b)< 32° b) 18-29% below reference values of normative
control data [45-47]. Also discriminating cut off
for cervicogenic headache [47,48].
Qualifier: Either a) or b)
1.2. Range of motion, lower
cervical
Flexion-extension < 17° 35% below reference values of normative control
data [44] resulting in 94% specificity.
1.3. Range of motion, upper and
lower cervical
Axial rotation < 109° 20% below reference values of normative control




Three sub-factors a) Maximal voluntary
contraction (MVC)
a)< 2,5 Nm a) Empirical experience, value indicating clear
impairment (Shaun O’Leary, personal
communication)
b) Endurance (50 % MVC) b)< 20 sec b) 88,5% specificity based on normative control
data (Pilot study, unpublished data, n = 26).Qualifier: Either a) or b)
2.2. Cervico-thoracic test
a) Flexion MVC a)< 40 N a) 95% specificity according to data simulation
based on [49,50].
b) Extension MVC b)< 140 N b) 95 % specificity according to data simulation
based on [49,50].Qualifier: Either a) or b)




a) Max weight / adjusted body weight
[52]: <0,12 kg/kg [28,53]
a) Cut off to discriminate between neck pain and
healthy: Specificity 81% [53]
b) Subjective rating of the
ability to carry and to lift
b) At least answer “rather bad, rather
difficult” on the questions “Because of your
neck problems, how do you manage to
carry/lift?” (≥4 on the scale 1 = Very good,
no problem; 6 = Very bad, very difficult/
impossibly)
b) Specificity data N/A. Chosen cut-off renders
47% of women with neck pain positive. (non-
published data, ISRCTN92199001)
Qualifier: a) and b) Comment: From a clinical perspective, we
thought it important to combine estimates of




a) Diagnosed trapezius myalgia
right or left
a) Criteria according to Ohlsson and
coworkers [27], with amendments [26].
a) Specificity N/A. In an attempt to sharpen and
objectify the trapezius myalgia criteria we have
added pain pressure measurements.
b) Pain pressure threshold of
the upper trapezius muscles
b)< 175 N right trapezius, < 168 N left
trapezius
b) 20 % below reference values of nonspecific
neck pain subjects without trapezius myalgia.
Qualifier: a) and b) The combination of criteria predicts 40%






Criteria of the Cervicogenic Headache
International Study Group [54] with
amendment of reduced range of motion
specific for the upper cervical levels and
palpable upper cervical joint dysfunction
[55].
The reason for the amendment is to increase the
sensitivity and specificity [55]. Note that the tests
of reduced upper cervical range of motion are




5.1. Symptoms and activity
limitations
a) Rather strong/often dizziness or balance





- Dizziness or balance
disturbances
b) Light dizziness or balance
disturbances (3 on both questions,
or >3 on one. Scale 1–6.) [28] and
headache associated to neck problems
(but not cervicogenic headache)
b) or c) Prediction 30%.
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Table 2 Decision model for selecting tailored treatment (Continued)
- Headache associated to neck
problems
- Difficulties to rotate the head
due to neck problems
c) Light dizziness or balance disturbances
and, due to neck problems, difficulties to
rotate the head
Disturbances of sensorimotor control and its
associations to symptoms like dizziness/balance
disturbances and headache is supported in the
literature (for references see [56,57].
(≥4 on scale 1–6.) To predict the number of positive cases for the
combinations in a), b) and c) we used 117
women with nonspecific neck pain (Own non-
published data, ISRCTN92199001):
Qualifier: Either a) or b)or c)
5.2. Cervical motor function < 170°/sec 50% below reference control data giving 97%
specificity [32]
Peak speed of cervical axial
rotation.
Reduced ability to perform fast cervical rotations
may reflect altered sensorimotor function in neck
pain patients [32].
MVC: Maximal voluntary contraction; C_PILE: Cervical Progressive Isoinertial lifting evaluation test.
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selecting tailored treatment components is presented in
Table 2. Immediately after the baseline assessment parti-
cipants are allocated to one of the three groups; tailored
(T), non-tailored (NT) and treatment-as-usual (TAU).
For participants allocated to the T-group, the result of
the decision model, a computerized decision algorithm
based on the baseline assessment, is used as a basis for a
preliminary selection of treatment components. The
project leader (PL, author MB) conveys written prelim-
inary treatment instructions to the IL. For the partici-
pants allocated to NT-group, two treatment components
are quasi-randomly selected and exclude components
that target the impaired function of the participant as
revealed by the result of the decision model. Participants
allocated to the TAU group do not receive any treatment
from the study and no restrictions to what they are
allowed to do. Participants in this group are told that
they will be contacted after three months for a re-test.
In order to identify specific problems in terms of activ-
ity limitations due to the neck-shoulder pain and the sig-
nificance of this limitation for the participant, the ILs
interview each participant allocated to the T- group
according to the Problem Elicitation Technique (PET)
[58]. This is done at the first treatment occasion. The
participant identifies six specific main problems together
with the IL, and rate the difficulty and importance of
each problem respectively, on 0–7 scales (higher scores
mean more difficult/more important). Finally, the identi-
fied problems are ranked by the participant in terms of
significance. The top three ranked problems are consid-
ered in the final composition of treatment components
for the participant in the T-group as well as on the func-
tional training of daily activities (see Functional training
of daily activities below). After the PET interview, the IL
and the PL meet to settle the final treatment direction.
To this end, the outcome of the PET is considered to-
gether with the result of the decision model within pre-
determined rules (see Rules for the decision model
below). Also, the prioritization order among treatmentcomponents is discussed if the participant has several
(>3) in her treatment profile. The degree of impairment
in relation to cut-off limits for each component as well
as the outcome of the PET are considered if a priority
order is set. Participants allocated to the NT-group are
also interviewed at the first treatment occasion, but the
questions included concern anamnesis and status fo-
cused on symptoms. The interview in both treatment
groups is concluded by asking the participants what
their personal goal with the rehabilitation would be. For
the T-group, this goal should be connected to the spe-
cific activities listed in PET.
To identify participants that may have a need for op-
tical correction and/or Visual Display Unit eye-glasses
the following questions are asked: 1. Do you wear
spectacles, prescribed by a certified optician during the
last 2 years, for near distance work? 2. Do you regularly
perform visually demanding near-work, such as working
with a computer or any other visually demanding near-
work tasks, which requires a well functioning near vision?
If the answer is “yes” on the latter question, participants
also answer 3. Do you experience strain in or around
your eyes at such work tasks? The following combina-
tions of answers qualify to be assessed by an optician:
Participants ≥40 years of age; “No” on question 1 and
“Yes” on the second question. Participants <40 years of
age; “No” on question 1, “Yes” on question 2 and “Yes”
on the third question. Only participants allocated to the
T-group are sent to optician on qualification.
Treatment components
The following treatment components were included (cf.
corresponding factors and tests described in Table 2 as
indicated by their numbers):
1. Manual therapy including mobilization treatment
and training to promote range of motion, derived
from the main factor 1. Cervical flexibility. The
three sub-factors shown in Table 2 (1.1, 1.2, 1.3)
outline largely the cervical levels and the planes of
motion to be treated. However, the specific cervical
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as the target of structure (e.g. joint structures and/or
extraarticular tissue like muscles and connective
tissues) are decided by the therapist according to
manual therapy principles [59]. Note that
participants qualified according to the sub-factor 1.3
receive mobilization/ROM-training in rotation of the
upper cervical only if cut-off 1.1.b. is reached.
2. Cranio-cervical flexion (CCF) exercise and strength
training neck-shoulder-arm, derived from the main
factor 2. Cervical strength. The sub-factor 2.1
qualifies for specific CCF exercise program [60,61].
Sub-factor 2.2 entails moderate to high intensity
strength training targeting neck-shoulder muscles.
The program is inspired by Ylinen and co-workers
[62] and the American College of Sports Medicine
Position Stand [63], the latter regarding principles
for movement speed, dose, load and frequency. 2.3
regards strength training for shoulder-arm muscles.
The same training principles is used here as in 2.2.
3. EMG-biofeedback training, derived from factor 3.
Trapezius myalgia. The biofeedback treatment
program consists of eight standardized exercises
with gradual progression of difficulty level followed
by training in specific tasks individualized for each
participant in the tailored treatment group. For
example, the specific task training could include
wearing EMG-biofeedback equipment while working
at a simulated computer-workstation with a stressful
task. In this situation, postural corrections and re-
education with the help of biofeedback may take
place. The aim is to teach/train the participant to
relax the upper trapezius muscles both in resting
position and in static and dynamic tasks (to lower
the contraction level of the trapezius muscle, obtain
muscle relaxation in between contractions and to
optimize the muscle strain during the task).
4. Treatment program for cervicogenic headache
(factor 4 in Table 2). This is composed of manual
therapy for the upper cervical and therapeutic
exercise including CCF exercise and low-load
endurance training for scapular muscles, mainly the
lower trapezius and the serratus anterior, as well as
postural correction of scapula in sitting. Thus, the
treatment is adapted to current best evidence
[64,65].
5. Neck coordination training / motor control training
deriving from factor 5. Sensorimotor control. There
are two sub-factors delineated in Table 2: 5.1.
Symptoms and activity limitations and 5.2. Cervical
motor function. Participants qualifying for 5.1.
receive a training program with exercise
progressions of difficulty in three levels. The
program is based on the work of Kristjansson andTreleaven [56,57] and consists of two main types of
exercises: cervical repositioning/movement control
and occulomotor exercises. The latter type consists
of smooth pursuit, saccades, gaze stability and eye-
head coordination exercises. Training of postural
stability is usually an important component for
patients with neck-shoulder pain and dizziness/
unsteadiness. We have chosen to integrate this
component in the other exercises at the third level
of difficulty. Training following 5.2. Cervical motor
function focuses on improving the ability to perform
fast cervical rotations. This may be done with partly
the same exercises as in 5.1., but also in a dark room
letting light flashes guide quick head movements in
different movement planes and with varying
trajectory length. In order to promote motor
learning of the exercises including retention and
transfer to other tasks and contexts, principles of
motor learning theory [66] is part of the training
program. For example, random practice in different
contexts is introduced in order to enhance retention
and transfer, and both internal (tactile, visual,
proprioceptive) and external (verbally or by video)
feedback is used to endorse the learning process.
Rules for the decision model
Each participant allocated to the T-group should have at
least two treatment components. If the outcome of the
test algorithm only yields one or no treatment compo-
nent, then the project group (PL and authors CH, MD)
decides which component(s) that should be added. This
decision is based on the relative closeness to cut-off for
each test as well as the outcome of the PET. The same
procedure is used if a treatment component is dropped
for some reason (e.g., due to anatomical limitations for
the treatment or other unforeseeable reasons as to why
the treatment is not desired or feasible) in the beginning
of the intervention period, and the participant thereby
gets less than two treatment components. An exception
to the rule of two treatment components is cervicogenic
headache (4.). The treatment following this diagnosis
consists of current best evidence [64,65], which involves
both manual therapy and exercise therapy including cra-
nio-cervical flexion exercise (see Treatment components
above). Cervicogenic headache treatment program is
only considered for participants in the tailored rehabili-
tation group.
A further component is chosen for T-group partici-
pants based on the same criteria if the decision algo-
rithm yields any of the combinations of components as
shown in Table 3
These listed component combinations are excluded as
treatment options in the NT-group. The rationale for ex-
cluding them is that these combinations of treatment do
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treatment occasions.
A third treatment component could also be considered
in the T-group if PET clearly indicates problems with activ-
ities that have close relation to a function/test included in
the decision model, and the result of that test was close to
cut-off for the specific individual.
If a participant experiences acute problems that nega-
tively influence functions not included in her treatment
component profile, the line of action from the therapist
is first watchful waiting with adjustment of the partici-
pant’s current components during one week. If the prob-
lem remains after one week, the therapist is allowed to
assess and treat with manual therapy maximally three
times to reduce pain [3,15] irrespective of the partici-
pant’s treatment profile.
Functional training of daily activities
In the latter half of the intervention period, functional
training of daily activities is introduced and the treat-
ment component program correspondingly reduced. For
the participants of the T-group, each treatment compo-
nent has predetermined suggestions for functional train-
ing exercises as a basis, but the idea is to individualize
this part as far as possible. A meeting is held between IL
and a person in the project group before commencing
the training to discuss ideas for individual-specific func-
tional training that targets the problematic activities pin-
pointed by the PET. Special concern is taken to organize
the training according to principles of motor learning
theory in order to enhance retention of the functional
training tasks and transfer to new tasks and environ-
ments [66]. Thus, variation of the training/random prac-
tice is emphasized [67] with a gradual progression
towards training in different contexts and increasingly
more complex movement tasks, and external feedback is
used. The functional training for the participants of theTable 3 Combinations of components that will lead to
the addition of a further component
Component 1 Component 2
1.1. Range of motion, upper cervical + 5.2. Cervical motor function
1.2. Range of motion, lower cervical + 5.2. Cervical motor function
1.3. Range of motion, upper and lower
cervical. Axial rotation.
+ 5.2. Cervical motor function
5.1. Symptoms and activity limitations + 5.2. Cervical motor function
1.1. Range of motion, upper cervical + 1.2. Range of motion, lower
cervical
1.1. Range of motion, upper cervical + 1.3. Range of motion, upper
and lower cervical. Axial
rotation.
1.2. Range of motion, lower cervical + 1.3. Range of motion, upper
and lower cervical. Axial
rotation.
1.1. Range of motion, upper cervical +
1.2. Range of motion, lower cervical
+ 1.3. Range of motion, upper
and lower cervical. Axial
rotation.NT-group follows a set training program with complex
movement exercises called “Muscle Action Quality
(MAQ) training” [68]. The exercises are believed to en-
hance the general fitness qualities strength, flexibility,
balance and movement control. The program is the
same for all NT-group participants and includes move-
ment exercises without weights and diagonal press- and
pull exercises with weights. Thus, the exercises are not
linked to specific daily activities as is the case for the
T-group.
Assessment
The baseline assessment has the following components
and purposes: i) laboratory assessment including tests of
motor control, strength and activity limitations, used for
the treatment decision model as well as treatment outcome
measures ii) clinical examination to categorize participants
according to specific diagnostic criteria [26,27,55,69,70]
used for the treatment decision model iii) clinical examin-
ation to confirm inclusion and exclusion criteria iv) ques-
tionnaires used for the treatment decision model and
treatment evaluation. During a period of three months be-
fore commencing the study, the test leader was trained in
performing assessments included in the test protocol. The
test leader is blinded with regard to the group allocation of
each subject.
Laboratory assessment, test of functioning
The laboratory assessment described in this section corres-
pond to factor 1 (Cervical flexibility), 2 (Cervical strength)
and 5 (Sensorimotor control) in Table 2.
Cervical flexibility and Sensorimotor control Cervical
flexibility is measured in tests of active range of motion of
the upper and lower cervical spine in flexion-extension
and of axial rotations in normal upright posture. The pro-
cedures for these tests are identical to the descriptions
given in [44]. Also, range of motion of axial head rotation
during maximal forward neck flexion is measured. The test
procedure is identical to that of Amiri et al. [45] except for
that the axial rotations are passively imposed by the test
leader and only two repetitions to each side (right/left) are
performed. Cervical motor control is assessed in a test of
maximal speed of cervical axial rotations [32]. All tests are
performed in sitting and are given in the order in which
they are described above. Kinematics of head movements
relative to the thorax are measured with an electromag-
netic tracking system (FASTRAK™, Polhemus Inc, USA)
[45]. Outcome measures for the tests are maximum range
of movement (degrees) and peak angular speed of the cer-
vical axial rotations (degrees/second).
Cervical strength, cervico-thoracic test Cervico-thoracic
extension and flexion (Figure 2) maximal voluntary
Figure 2 Cervico-thoracic flexion test. Sitting measurement of
isometric cervico-thoracic flexion strength, maximal voluntary
contraction (with permission).
Figure 3 Cranio-cervical flexion test. Standing measurements of
isometric cranio-cervical flexion strength, maximal voluntary
contraction, and endurance 50% of maximal voluntary contraction
(with permission).
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procedure as Salo and co-workers [49]. The strength
values are expressed in Newtons.
Cervical strength, cranio-cervical flexion test The
measurement device used for this test is based on
O’Leary et al. [71], but in conformity with Van Wyke
et al. [72] the test is performed in a standing position
(Figure 3). In the starting position the dynamometer re-
sistance arm of the measurement device is placed under
the inferior border of the participant’s mandible. The
dynamometer axis is aligned to the concha of the ear
which corresponds to the axis of rotation for the
atlanto-occipital joint over which the cranio-cervical
flexor muscle group (the longus capitis and rectus capitis
anterior muscles) acts. After getting accustomed to the
device, instructions and a practice session in doing an
isolated cranio-cervical flexion movement, the partici-
pant performs three maximum effort trials. If the last
trial exceeds the second last by >5%, then a further trial
is carried-out. Thereafter, the test leader explains and
visualizes the endurance 50% MVC test with help of a
computer screen showing the level of 50% MVC. The
participant is asked to press against the resistance arm
so that the torque curve reaches the 50%-level and to
keep it there as long as possible. If the torque drops
below the 50%-level, the test leader immediately
instructs the participant to return to the level. The test
ends either because of failure to keep the torque at the
required level or when 10 accumulated seconds below
the 50%-level bar has passed. The outcome of cranio-
cervical flexion MVC test is torque (Newtonmeter) and
the endurance 50% MVC test is time (seconds).
Cervical strength, arm strength in lifting task The cer-
vical progressive isoinertial lifting evaluation test (C-PILE)
involves lifting weights placed in a box from waist height
to shoulder height with progressively increasing loads
[51,73,74].
Clinical examination
Categorizing individuals with neck pain
Neck pain participants are examined by a physiotherap-
ist according to a standardized physical examination
protocol of the neck [27], with amendments presented
by Juul-Kristensen and co-workers [26]. This protocol
defines criteria for the diagnoses Tension neck syndrome,
cervicalgia, trapezius myalgia and cervical syndrome.
Measurement of pressure pain threshold of neck muscles
and pain provocation of neck facet joints
For quantification of muscle soreness in the upper trapezius
muscles we use algometer pressure pain threshold (PPT)
measurements. For acquaintance with the procedure, a firstpressure pain test is performed distally of the left arm lat-
eral epicondylia. Thereafter, the following measures are
made: Right and left upper trapezius muscle, in the middle
between processus spinosus of C7 and acromion, and a
reference PPT in the tibialis anterior muscle of each leg.
Three measurements are made on each spot, alternating
between right and left side. The PPTs of the trapezius mus-
cles are part of the decision model for treatment (see Table 2
and Treatment components above) as well as a secondary
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cervical spine are palpated for pain provocation and altered
tissue resistance to movement as an indication of joint dys-
function [59]. The facet joint assessment is only performed
on participants who are suspected to have cervicogenic
headache (see below).
Assessment of specific diagnoses
The assessment for cervicogenic headache is based on the
major criteria of Cervicogenic Headache International
Study Group [54] with amendment of reduced ROM in
the upper cervical segments and palpable upper cervical
joint dysfunction [55]. Examination of rhizopathy [27] and
vestibular dysfunction is made to comply with exclusion
criteria. Participants who indicate pain in all four quadrants
of the body in the pain drawing are examined for fibro-
myalgia/generalised pain [40]. Participants are excluded if
the diagnosis is confirmed.
Questionnaires
The following questionnaires are used for treatment evalu-
ation: General improvement, the Patient Global Impression
of Change scale (PGICS) [75]; Pain intensity, 0–10
Numeric Rating Scale (NRS) [75]; Pain localization, pain
drawing [23]; Physical functioning, NDI [24], Symptoms
and functional limitations, the Profile Fitness Mapping
neck questionnaire (ProFitMap-neck), a neck specific ques-
tionnaire [28]; Working capacity, questions regarding the
impact of neck symptoms on the quantity and quality of
performed work [25]. Self-estimated improvement during
treatment is measured after 10 and 20 treatment sessions
with PGICS and NRS.
For measurement of health economy EuroQoL 5-
dimensions (EQ-5D) [76] and the Short Form Health Survey
(SF-36) [77], reflecting health-related quality of life, are used.
In addition, we apply measures of the cost of intervention,
self-reported absence from work due to neck pain, prescrip-
tion and consumption of drugs and health care, respectively.
Work load exposure is assessed by questionnaires and
observations. Psychosocial factors are estimated by
selected scales from the General Nordic Questionnaire
for Psychological and Social Factors at Work (QPS Nor-
dic) [78]: Quantitative job demands; Decision demands;
Learning demands; Control of decisions; Control of
work pacing; Perception of mastery; Support from super-
ior; Support from coworkers; Support from friends and
relatives; Social climate. We also use a question on per-
ceived stress with a 5-point response scale [79]. Finally,
Physical factors are assessed by observations in the
workplace (Quick Exposure Check) [80].
All participants allocated to the T- or NT-groups are also
followed qualitatively during the intervention period
through standardized as well as open ended questions after
10, 20 and at the last treatment session, respectively.Primary outcome measures
1. Physical functioning, measured with the Neck
Disability Index (NDI)
2. Average pain intensity last week, measured with the
Numeric Rating Scale (NRS)
Secondary outcome measures
1. General improvement, assessed by the Patient
Global Impression of Change scale (PGICS)
2. Symptoms, measured by the symptom index of the
Profile Fitness Mapping neck questionnaire
(ProFitMap-neck)
3. Capacity on the quality and quantity to work in the
latest 6 weeks due to neck problems ([1 – (quality/
10) × (quantity/10)] × 100%)
4. Pressure pain threshold of m. trapezius, assessed
with pressure algometer measurement
Other outcome measures
1. Self-estimated improvement during treatment, for
General improvement, “much improved” or “very
much improved” on PGICS; for Pain intensity, no
pain last week (NRS)
2. Functional limitations and compound total score,
assessed by the Profile Fitness Mapping neck
questionnaire (ProFitMap-neck)
3. Cervical range of motion (active flexion-extension;
active axial rotation; passive flexion-rotation)
4. Peak speed in cervical axial rotation
5. Cranio-cervical flexion endurance (50% of maximum
voluntary contraction)
6. Lifting capacity, assessed by the cervical progressive
isoinertial lifting evaluation test (C-PILE)
7. Physical activity, measured with LIV 2000
8. Health-related quality of life for clinical and
economic appraisal, assessed by the EQ-5D
9. Questions on reporting sick, and consumption of care
10.Quality of life - Mental health, assessed by the
Mental component summary in the SF-36
11.Quality of life – Physical Health, assessed by the
Physical component summary in the SF-36
12.Area of pain distribution, assessed by pain drawings
13.Adverse events. Open ended questions, and PGICS
administered after 10, 20 and the last treatment
session. “Much worse” or “Very much worse” on the
PGICS is equalized with an adverse event.
Statistical methods
Power
Power calculations with the one-way analysis of variance
(ANOVA) routine (nQuery Advisor 3.0) are presented
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measures Physical functioning, and Average pain inten-
sity last week. For physical functioning measured with
NDI, a clinical important difference is between 6–10
NDI% [81]. Reference data from a parallel clinical trial
(ISRCTN92199001) showed that the NDI standard devi-
ation (SD) was 10.3 NDI% (based on 117 women with
neck-shoulder pain). To obtain a power of 0.8, given a
difference of 6 NDI% between any of the three groups,
20 individuals are required in each group (alfa = 0.05).
For the average pain intensity last week, the smallest
clinical important pain reduction measured with NRS is
approximately 15% [43]. In the above mentioned clinical
trial, the SD was 15.5 NRS%. Given these facts, 20 indi-
viduals in each group is sufficient to obtain a power of
>0.8 for a difference of 15 NRS% between any of the
three groups (alfa = 0.05). On the basis of this power cal-
culation we aim at recruiting 40 participants for each
group, which would give us a satisfactory safety margin
to retain a power of 0.8 or higher through the trial.
Data analyses
Statistical analyses will be performed with IBM SPSS sta-
tistics version 20.0 and the level of significance is set at p
< 0.05. Primary and secondary outcome variables will be
analysed according to intention-to-treat (ITT) and per
protocol (PP). In ITT analyses, all participants allocated
to the study groups constitute the study sample, whereas
only participants that complete a minimum of 14 treat-
ment sessions (≥50% of the total number of treatment
sessions) and have valid measurements at baseline and
follow-up will be the study sample in the PP analyses. In
analyses of the main hypothesis, effect size and the treat-
ment effect (between-group mean differences and 95%
CI) will be determined for the primary and secondary
outcome variables by means of analysis of covariance
(ANCOVA) utilising mixed model approach, with treat-
ment as fixed factor and baseline measurement of the
outcome variable as covariate. If the residuals of an
ANCOVA model are not normally distributed, appropri-
ate transformations of relevant variables will be used in
the analysis. Full model for post hoc tests will be used.
For the variable General Improvement (PGICS) compar-
isons between the groups will be made by proportional
odds model (ordinal logistic regression) and estimation
of the absolute effect (risk difference) with 95% CI.
Analyses regarding the secondary aim to evaluate the
importance of physical and psychosocial factors in the
workplace on long-term treatment outcomes will be
handled in the following way. Participants that show an
improvement exceeding minimal clinically important dif-
ference for the primary outcomes (6 NDI% or 15 NRS%),
at follow-up 1 (one week after intervention), will be classi-
fied as “improved”. Long term effects (measured at 12-month follow up) of workload factors on primary outcome
variables and the secondary variable Capacity on the qual-
ity and quantity to work will be tested for the group
“improved” with General Linear Model ANCOVA where
outcome values at follow-up 1, as well as the factors for
work load exposure (see Questionnaires), are covariates.
Exposure of workload is measured 1 week after end of
intervention. At 6-month and 12-month follow-up partici-
pants answer questions on if exposure has changed the
latest 6 month. Those whose self-rated physical or psycho-
social work exposure markedly changed (measured with 2
questions) between follow-up 1 and 12-month test will be
excluded for further analyses related to the secondary aim.
The third aim to evaluate the cost-effectiveness in the
groups, cost-utility analyses (CUA) comparing measures
of health gain and measures of costs will be performed
[82]. For this purpose, estimates of quality adjusted life
year (QALY) gains based on EQ-5D will be calculated,
followed by cost by QALY ratio.
Discussion
We delimit the study to participants without psycho-
logical ill-health to avoid the interventions and the deci-
sion model to get too diversified and complex. We
acknowledge, however, that psychological ill-health is a
common co-morbidity to chronic neck pain. Future
studies should therefore aim at including this aspect in a
widened treatment decision model. Our study focuses
on women since women are known to have a signifi-
cantly greater risk for neck disorders than men [20].
This means, however, that the results of the study can-
not readily be extrapolated to men. Finally, no adverse
events or side-effects are expected from the tests or
treatments given in the study.
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